MSF To Urge India To Overturn Pfizer Patent On Pneumonia Vaccine
Médecins Sans Frontières: India: Unmerited Pfizer patent on pneumonia vaccine limits access for children
“Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine, said Médecins Sans Frontières (MSF). MSF is set to argue [on Tuesday] in the High Court of Delhi, India that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act. The U.S.-based drug corporation’s unmerited patent prevents vaccine manufacturers in India from developing the vaccine until 2026, depriving countless children of the opportunity to be protected against pneumonia, which kills 2,500 kids per day…” (11/20).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.